Duke logo

SBRT In Early Stage Breast Cancer - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn about the cosmetic outcomes in breast cancer patients who are treated with this single dose of radiation.

This study will also help us learn about how breast cancer responds to radiation so that in the future, radiation can be matched to the patient's particular tumor.

What is the Condition Being Studied?

Early stage breast cancer

Who Can Participate in the Study?

Adults aged 50 years or older who:
- Are diagnosed with early stage breast cancer
- Have a tumor that measures less than or equal to 2cm
- Have a negative pregnancy test

Age Group
Adults

What is Involved?

If you join this study, you will:
- Have a MRI scan and CT scan to find the tumor and create a plan for your radiation treatment
- A single radiation dose of 21 Gy (Gray) will be given to your breast cancer.
- Surgery will be done to remove your tumor, within 10 days of completing radiation.
- We will obtain tumor tissue from your surgery to understand how breast cancer responds to radiation.
- Digital photographs and quality of life questionnaires will be obtained prior to the single radiation dose and at 6 months, 1 year, 2 years and 3 years after treatment.
-- The photographs will be used to see how your breasts look before and after surgery and radiation treatment.

Study Details

Full Title
A Phase II Evaluation of Preoperative Single-Fraction Partial Breast Radiotherapy in Early Stage Breast Cancer
Principal Investigator
Radiation Oncologist
Protocol Number
IRB:PRO00063848
NCT:NCT02482376
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698